Our study has laid a foundation for future investigations to further explore the potential of RABEX-5 mRNA as a diagnostic marker for monitoring biochemical recurrence and as an effective therapeutic target for preventing and treating prostate cancer. The gene discussed is RABGEF1; the disease is Familial prostate cancer.